Enhanced External Counter-Pulsation (EECP)—This non-invasive heart therapy is truly a valid cardiovascular treatment for ischemic heart disease and congestive heart failure. Although developed more than 50 years ago, I’ll tell you most cardiologists, especially heart surgeons, are disinterested in EECP. It is, as they know, a strong alternative to bypass surgery.
EECP, in many cases, is paid for by Medicare and Blue Cross and is approved by the FDA. It costs about $10,000 to $12,000 versus $50,000 to $70,000 for bypass surgery, which is also a much greater health risk.
EECP should be used as a first option before bypass surgery. At this point this is unthinkable to conventional heart medicine that runs on huge amounts of money.
The testimonials of patients with severe angina are full of the highest praise. I have talked to one extremely serious heart patient who called EECP a miracle! He was an invalid, and now he’s back to life, even playing golf.
EECP improves coronary flow reserve significantly at rest and with increased exercise tolerance.
The main, essential feature of the EECP mechanism is the development and recruitment of collateral arteries. Collateral, or new arteries, implies more circulation and less angina.
Yes, this is the spontaneous growth and development of brand new arteries on and around the heart to supply new and improved blood flow and oxygen to the heart.
The heart patient knows only too well the benefits of vasodilatation and increased blood flow to the heart. Extra dilation of the coronary arteries plus added blood flow via the new collaterals means greatly improved quality of life for an extended period, maybe several years, as experience has shown.
The data suggests that EECP therapy not only improves myocardial perfusion (circulation), but also decreases cardiac workload.
Some patients who may be excluded are patient who have:
- Had myocardial infarction in the preceding three months
- Had intervention in the preceding two weeks
- Unstable angina (i.e., high risk angina)
- Overt congestive heart failure
- Left ventricular ejection fraction of less than 30 percent
- Significant valvular disease
- Blood pressure more than 180/100 mm Hg
- A permanent pacemaker or implantable cardioverter defibrillator
- Non-bypassed left main stenosis of more than 50 percent
- Severe peripheral vascular disease, phlebitis, deep vein thrombosis, etc.
- Atrial fibrillation or frequent ventricular premature construction that would interfere with enhanced external counter-pulsation triggering (i.e., your electrocardiogram has to be reliable enough for the machine to work.)
All this may sound very limiting, but my personal interview was with a serious cardiac patient who did exceedingly well. He previously had 17 procedures from two bypass surgeries and many stents, etc. If you have any of these limitations named, I would still pursue EECP evaluation by a cardiologist to make sure that you aren’t excluded. If your cardiologist is indifferent to EECP, then get another cardiologist.
My research reveals that EECP is the best possible therapy before bypass surgery or even as a preventive for everybody. Why not overhaul your vascular system before you have a problem, particularly if heart disease is in your family.
External Enhanced Counter-Pulsation (EECP) coupled with a steady oral chelation and nutritional protocol could easily add many quality years to your life.
I have had this full treatment for seven weeks. I know that the results are significant and I have no angina except during extra heavy work or exertion.
I have no trouble predicting that within a few years EECP therapy will become public knowledge and in wide use. This activity will trigger more research and the development of a far more sophisticated and efficient EECP. This is very exciting—except maybe not for the bypass surgery industry.